MedTrace Logo

Pharmacokinetics and Pharmacdynamics of Sildenafil

NCT00718185 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2015-03-12

No results posted yet for this study

Summary

The study is being done to investigate what happens to sildenafil in the body and how long it takes to get rid of this drug. Understanding how long the drug stays in the body and how it is changed by the body will help doctors determine the best dose. We also want to learn how well the medicine works based on the size of the dose or amount in the bloodstream.

Conditions

  • Pulmonary Hypertension

Interventions

PROCEDURE

Obtain blood specimens

Obtain blood samples at multiple timepoints.

Sponsors & Collaborators

Principal Investigators

  • Athena Zuppa, MD · Children's Hospital of Philadelphia

Eligibility

Min Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00718185 on ClinicalTrials.gov